MILWAUKEE, Aug. 5, 2021 /PRNewswire/ -- Ademi LLP is investigating possible securities fraud claims against Zymergen (NASDAQ: ZY). The investigation results from inaccurate statements Zymergen may have made regarding its business operations and prospects. Click here to learn more about...
from PR Newswire: https://ift.tt/3lwVPNv
No comments:
Post a Comment